Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
13.97
-1.15 (-7.61%)
At close: Nov 15, 2024, 4:00 PM
14.05
+0.08 (0.57%)
After-hours: Nov 15, 2024, 7:45 PM EST
Intellia Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 43.09 | 36.28 | 52.12 | 33.05 | 57.99 | 43.1 | |
| Revenue Growth (YoY) | -16.77% | -30.40% | 57.69% | -43.01% | 34.55% | 41.63% | |
| Cost of Revenue | 458.42 | 435.07 | 419.98 | 229.81 | 150.41 | 108.41 | |
| Gross Profit | -415.33 | -398.79 | -367.86 | -196.75 | -92.41 | -65.31 | |
| Selling, General & Admin | 122.38 | 116.5 | 90.31 | 71.1 | 44.17 | 41.06 | |
| Operating Expenses | 122.38 | 116.5 | 90.31 | 71.1 | 44.17 | 41.06 | |
| Operating Income | -537.71 | -515.29 | -458.16 | -267.85 | -136.58 | -106.37 | |
| Interest & Investment Income | 49.64 | 49.83 | 8.54 | 1.28 | 2.35 | 6.84 | |
| Earnings From Equity Investments | -4.73 | -15.63 | -11.08 | -1.33 | - | - | |
| EBT Excluding Unusual Items | -492.8 | -481.09 | -460.7 | -267.89 | -134.23 | -99.53 | |
| Other Unusual Items | - | -0.1 | -13.49 | - | - | - | |
| Pretax Income | -522.28 | -481.19 | -474.19 | -267.89 | -134.23 | -99.53 | |
| Net Income | -522.28 | -481.19 | -474.19 | -267.89 | -134.23 | -99.53 | |
| Net Income to Common | -522.28 | -481.19 | -474.19 | -267.89 | -134.23 | -99.53 | |
| Shares Outstanding (Basic) | 96 | 89 | 77 | 71 | 56 | 47 | |
| Shares Outstanding (Diluted) | 96 | 89 | 77 | 71 | 56 | 47 | |
| Shares Change (YoY) | 11.02% | 15.33% | 8.57% | 26.63% | 18.50% | 9.70% | |
| EPS (Basic) | -5.44 | -5.42 | -6.16 | -3.78 | -2.40 | -2.11 | |
| EPS (Diluted) | -5.44 | -5.42 | -6.16 | -3.78 | -2.40 | -2.11 | |
| Free Cash Flow | -363.06 | -408.07 | -346.85 | -237.79 | -53.5 | -110.03 | |
| Free Cash Flow Per Share | -3.78 | -4.60 | -4.51 | -3.35 | -0.96 | -2.33 | |
| Gross Margin | - | - | - | - | -159.35% | -151.52% | |
| Operating Margin | -1247.99% | -1420.51% | -879.04% | -810.37% | -235.51% | -246.78% | |
| Profit Margin | -1212.19% | -1326.51% | -909.78% | -810.49% | -231.46% | -230.92% | |
| Free Cash Flow Margin | -842.63% | -1124.94% | -665.46% | -719.41% | -92.25% | -255.28% | |
| EBITDA | -527.52 | -506.32 | -450.59 | -260.96 | -130.27 | -100.78 | |
| EBITDA Margin | - | - | - | - | -224.63% | -233.81% | |
| D&A For EBITDA | 10.19 | 8.98 | 7.57 | 6.89 | 6.31 | 5.59 | |
| EBIT | -537.71 | -515.29 | -458.16 | -267.85 | -136.58 | -106.37 | |
| EBIT Margin | - | - | - | - | -235.51% | -246.78% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.